Cytek Investor Presentation Deck

Investing to Capture the Cell Analysis Opportunity Validated Technology Platform Broad Customer Base and Global Presence Strong Financial Profile 1,501 Units Placed 881 Publications CYTEK TRANSCEND THE CONVENTIONAL 900+ Customers 40+ Countries $155M $21M TTM Revenue/ A-EBITDA $342M Cash No debt CE-IVDD Tonbo Cell Sorter Reagents Northern Lights Aurora B 2022 2021 2021 2020 2018 2017 4

View entire presentation